Cargando…

Miltefosine increases macrophage cholesterol release and inhibits NLRP3-inflammasome assembly and IL-1β release

Miltefosine is an FDA approved oral drug for treating cutaneous and visceral leishmaniasis. Leishmania is a flagellated protozoa, which infects and differentiates in macrophages. Here, we studied the effects of Miltefosine on macrophage’s lipid homeostasis, autophagy, and NLRP3 inflammasome assembly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacano, Amanda J., Lewis, Harvey, Hazen, Jennie E., Andro, Heather, Smith, Jonathan D., Gulshan, Kailash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668382/ https://www.ncbi.nlm.nih.gov/pubmed/31366948 http://dx.doi.org/10.1038/s41598-019-47610-w

Ejemplares similares

Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages
por: Luheshi, Nadia M, et al.
Publicado: (2012)

Ti Ions Induce IL-1β Release by Activation of the NLRP3 Inflammasome in a Human Macrophage Cell Line
por: Pettersson, Mattias, et al.
Publicado: (2022)

Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages
por: Amaral, Eduardo P., et al.
Publicado: (2018)

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
por: Köse-Vogel, Nilay, et al.
Publicado: (2019)

ATP release and purinergic signaling in NLRP3 inflammasome activation
por: Gombault, Aurélie, et al.
Publicado: (2013)

Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis
por: Opoku, Emmanuel, et al.
Publicado: (2021)

Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis
por: Trachalaki, Athina, et al.
Publicado: (2021)

Compliant Substrates Enhance Macrophage Cytokine Release and NLRP3 Inflammasome Formation During Their Pro-Inflammatory Response
por: Escolano, Joan-Carles, et al.
Publicado: (2021)

Activation of NLRP1 and NLRP3 inflammasomes contributed to cyclic stretch-induced pyroptosis and release of IL-1β in human periodontal ligament cells
por: Zhao, Dan, et al.
Publicado: (2016)

NLRP3 inflammasome triggers interleukin‐37 release from human monocytes
por: Gritsenko, Anna, et al.
Publicado: (2022)

Pregnane X Receptor Activation Triggers Rapid ATP Release in Primed Macrophages That Mediates NLRP3 Inflammasome Activation
por: Hudson, Grace, et al.
Publicado: (2019)

Annexin A1 Regulates NLRP3 Inflammasome Activation and Modifies Lipid Release Profile in Isolated Peritoneal Macrophages
por: Sanches, José Marcos, et al.
Publicado: (2020)

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
por: Rajamäki, Kristiina, et al.
Publicado: (2010)

Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release
por: Martín-Sánchez, Fátima, et al.
Publicado: (2017)

Human T(H)17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation
por: Chao, Ying-Yin, et al.
Publicado: (2023)

NLRP3 Inflammasome Involved with Viral Replication in Cytopathic NADL BVDV Infection and IFI16 Inflammasome Connected with IL-1β Release in Non-Cytopathic NY-1 BVDV Infection in Bovine Macrophages
por: Gallegos-Rodarte, Claudia, et al.
Publicado: (2023)

Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes
por: Zheng, Shu-cong, et al.
Publicado: (2015)

Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation
por: de la Roche, Marianne, et al.
Publicado: (2018)

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages
por: Gangopadhyay, Anu, et al.
Publicado: (2022)

Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
por: Hillegass, Jedd M, et al.
Publicado: (2013)

Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc(–/–) and Nlrp3(–/–) Mice
por: Chen, Yu, et al.
Publicado: (2019)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation
por: Ives, Annette, et al.
Publicado: (2015)

IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome
por: Ge, Yun, et al.
Publicado: (2021)

Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
por: Martín-Sánchez, F, et al.
Publicado: (2016)

Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model
por: He, Wei, et al.
Publicado: (2019)

P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
por: Bockstiegel, Judith, et al.
Publicado: (2023)

Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome
por: Chiu, Hsiao-Wen, et al.
Publicado: (2019)

PM2.5 activated NLRP3 inflammasome and IL-1β release in MH-S cells by facilitating autophagy via activating Wnt5a
por: Yuan, Guanli, et al.
Publicado: (2022)

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
por: Stutz, Andrea, et al.
Publicado: (2017)

The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2011)

The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages
por: Finucane, Orla M., et al.
Publicado: (2019)

Critical Role for the NLRP3 Inflammasome in Mediating IL-1β Production in Shigella sonnei-Infected Macrophages
por: Li, Lan-Hui, et al.
Publicado: (2020)

Annatto Tocotrienol Attenuates NLRP3 Inflammasome Activation in Macrophages
por: Buckner, Teresa, et al.
Publicado: (2017)

The NLRP3 inflammasome in macrophages is stimulated by cell‐free hemoglobin
por: Shaver, Ciara M., et al.
Publicado: (2020)

NKT Cells Join the Two Step for Inflammasome-Independent IL-1β Release
por: Bezbradica, Jelena S., et al.
Publicado: (2020)

Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction
por: Chevriaux, Angélique, et al.
Publicado: (2020)

ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial for Inflammasome Activation in Macrophages
por: Ayna, Gizem, et al.
Publicado: (2012)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rk1gu1o49nedc0haelgjfh0bn6